Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Am J Forensic Med Pathol ; 42(3): 263-266, 2021 Sep 01.
Article in English | MEDLINE | ID: mdl-33394682

ABSTRACT

ABSTRACT: Acute hemorrhagic leukoencephalitis (AHL) is an acute, hemorrhagic demyelinating disease thought to be caused by an immune-mediated process. Acute hemorrhagic leukoencephalitis is both diagnostically challenging and fatal in the majority of cases. We present two cases of AHL unexpectedly diagnosed at autopsy. These cases demonstrate the often nonspecific and challenging nature of AHL clinical presentation, review neuropathological mimics, and emphasize the importance of considering this diagnosis in the forensic setting.


Subject(s)
Leukoencephalitis, Acute Hemorrhagic/diagnosis , Adolescent , Brain/pathology , Fatal Outcome , Female , Humans , Male , Middle Aged
2.
Int J Surg Pathol ; 18(4): 255-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19578047

ABSTRACT

Wilms's tumor gene (WT1) is overexpressed in a variety of hematologic malignancies and solid tumors. Recently, WT1 protein has been considered as a molecular target of cancer immunotherapy for several solid tumors and as a tool for monitoring minimal residual disease in leukemia patients. There are only few investigations on WT1 expression in central nervous system neoplasms, which suggest that the WT1 gene may play an important role in tumorigenesis of primary astrocytic tumors and that high-grade tumors express high levels of WT1 proteins. We examined 50 low-grade and high-grade gliomas using tissue microarray and immunohistochemical methods to identify WT1 protein, P53, Ki-67, GFAP, NFP, EGFR, nestin, and Neu-N expression. WT1 and nestin shared overlapping expression in all gliomas and were increased in high-grade examples, highlighting their potential use as diagnostic and prognostic tumor markers. Our results support the combined role of WT1 and nestin in glial tumorigenesis and progression.


Subject(s)
Astrocytoma/metabolism , Brain Neoplasms/metabolism , Intermediate Filament Proteins/metabolism , Nerve Tissue Proteins/metabolism , WT1 Proteins/metabolism , Adolescent , Adult , Aged , Astrocytoma/pathology , Biomarkers, Tumor/metabolism , Brain Neoplasms/pathology , Child , Child, Preschool , Female , Humans , Immunohistochemistry , Infant , Male , Middle Aged , Nestin , Tissue Array Analysis , Young Adult
3.
Mil Med ; 175(7 Suppl): 18-24, 2010 Jul.
Article in English | MEDLINE | ID: mdl-23634474

ABSTRACT

The Combat Wound Initiative (CWI) program is a collaborative, multidisciplinary, and interservice public-private partnership that provides personalized, state-of-the-art, and complex wound care via targeted clinical and translational research. The CWI uses a bench-to-bedside approach to translational research, including the rapid development of a human extracorporeal shock wave therapy (ESWT) study in complex wounds after establishing the potential efficacy, biologic mechanisms, and safety of this treatment modality in a murine model. Additional clinical trials include the prospective use of clinical data, serum and wound biomarkers, and wound gene expression profiles to predict wound healing/failure and additional clinical patient outcomes following combat-related trauma. These clinical research data are analyzed using machine-based learning algorithms to develop predictive treatment models to guide clinical decision-making. Future CWI directions include additional clinical trials and study centers and the refinement and deployment of our genetically driven, personalized medicine initiative to provide patient-specific care across multiple medical disciplines, with an emphasis on combat casualty care.


Subject(s)
High-Energy Shock Waves/therapeutic use , Military Personnel , Translational Research, Biomedical , Wounds and Injuries/therapy , Biomarkers , Burns/therapy , Clinical Trials as Topic , Humans , Neovascularization, Physiologic , Public-Private Sector Partnerships , United States , Warfare , Wound Healing
4.
Head Neck Pathol ; 3(2): 116-30, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19644540

ABSTRACT

Primary extracranial meningiomas are rare neoplasms, frequently misdiagnosed, resulting in inappropriate clinical management. To date, a large clinicopathologic study has not been reported. One hundred and forty-six cases diagnosed between 1970 and 1999 were retrieved from the files of the Armed Forces Institute of Pathology. Histologic features were reviewed, immunohistochemistry analysis was performed (n = 85), and patient follow-up was obtained (n = 110). The patients included 74 (50.7%) females and 72 (49.3%) males. Tumors of the skin were much more common in males than females (1.7:1). There was an overall mean age at presentation of 42.4 years, with a range of 0.3-88 years. The overall mean age at presentation was significantly younger for skin primaries (36.2 years) than for ear (50.1 years) and nasal cavity (47.1 years) primaries. Symptoms were in general non-specific and reflected the anatomic site of involvement, affecting the following areas in order of frequency: scalp skin (40.4%), ear and temporal bone (26%), and sinonasal tract (24%). The tumors ranged in size from 0.5 up to 8 cm, with a mean size of 2.3 cm. Histologically, the majority of tumors were meningothelial (77.4%), followed by atypical (7.5%), psammomatous (4.1%) and anaplastic (2.7%). Psammoma bodies were present in 45 tumors (30.8%), and bone invasion in 31 (21.2%) of tumors. The vast majority were WHO Grade I tumors (87.7%), followed by Grade II (9.6%) and Grade III (2.7%) tumors. Immunohistochemically, the tumor cells labeled for EMA (76%; 61/80), S-100 protein (19%; 15/78), CK 7 (22%; 12/55), and while there was ki-67 labeling in 27% (21/78), <3% of cells were positive. The differential diagnosis included a number of mesenchymal and epithelial tumors (paraganglioma, schwannoma, carcinoma, melanoma, neuroendocrine adenoma of the middle ear), depending on the anatomic site of involvement. Treatment and follow-up was available in 110 patients: Biopsy, local excision, or wide excision was employed. Follow-up time ranged from 1 month to 32 years, with an average of 14.5 years. Recurrences were noted in 26 (23.6%) patients, who were further managed by additional surgery. At last follow-up, recurrent disease was persistent in 15 patients (mean, 7.7 years): 13 patients were dead (died with disease) and two were alive; the remaining patients were disease free (alive 60, mean 19.0 years, dead 35, mean 9.6 years). There is no statistically significant difference in 5-year survival rates by site: ear and temporal bone: 83.3%; nasal cavity: 81.8%; scalp skin: 78.5%; other sites: 65.5% (P = 0.155). Meningiomas can present in a wide variety of sites, especially within the head and neck region. They behave as slow-growing neoplasms with a good prognosis, with longest survival associated with younger age, and complete resection. Awareness of this diagnosis in an unexpected location will help to avoid potential difficulties associated with the diagnosis and management of these tumors.


Subject(s)
Meningioma/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Child , Child, Preschool , Female , Humans , Immunohistochemistry , Infant , Kaplan-Meier Estimate , Male , Meningioma/metabolism , Meningioma/mortality , Middle Aged , Neoplasm Recurrence, Local/epidemiology , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/pathology , Prognosis , Young Adult
5.
Childs Nerv Syst ; 23(2): 249-53, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17009008

ABSTRACT

OBJECT: We report the rare finding of trimyelia with divergent cord pathways in a 33 5/7-week-old fetus who died shortly after spontaneous vaginal delivery. METHODS: The main autopsy findings were three separate and distinct spinal cords, arising from the medulla and exiting through three separate foramina magni. The two lateral cords coursed toward each upper extremity and the medulla split into two halves that rejoined to form a central cervical cord. Further evaluation of this anomaly revealed agenesis of the cerebellar vermis and cystic dilation of the fourth ventricle. Microscopic cross-sections of the two lateral cords demonstrated well-formed central canals, white matter, and central gray with motor neurons. Sections of the abnormal mid-cervical cord demonstrated abnormally structured cord parenchyma without central canals. CONCLUSIONS: Some features were consistent with iniencephaly; however, defects of the occipital bone, anterior spina bifida, and shortening of the spinal cord were absent. Although agenesis of the cerebellar vermis and cystic dilation of the fourth ventricle indicate Dandy-Walker syndrome, other features such as hydrocephalus, agenesis of the corpus callosum, infundibular hamartomas, and malformations of the inferior olives or an occipital encephalocele were absent. The possible pathogenesis of this intriguing pathological entity is briefly discussed.


Subject(s)
Brain/abnormalities , Foramen Magnum/abnormalities , Foramen Magnum/pathology , Spinal Cord/abnormalities , Spinal Cord/pathology , Brain/pathology , Fourth Ventricle/pathology , Humans , Infant , Male
6.
J Neurosurg ; 104(2 Suppl): 143-8, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16506503

ABSTRACT

Primary germ cell neoplasms of the central nervous system typically develop as midline mass lesions during the first three decades of life. The authors present two cases with atypical clinicopathological features that stimulate discussion on the diagnosis and management of these tumors. The first patient was an 11-year-old boy of Japanese-American heritage who presented with a 6-month-long history of cognitive decline, difficulty swallowing, unsteady gait, and intermittent right-sided posturing. The initial magnetic resonance (MR) image of the brain displayed a mildly increased T2 signal in the cerebral peduncles, putamen, and globus pallidus bilaterally. Follow-up MR images showed an increase in the T2 signal abnormality in the left basal ganglia. The second patient was a 10-year-old Caucasian boy who presented with diabetes insipidus and subsequently displayed progressive fatigue, involuntary eye and mouth movements, and obsessive-compulsive behavior. An MR image demonstrated signs of mineral deposition and foci of increased T2 signal in both basal ganglia. Follow-up MR images demonstrated a progressive increase in the T2 signal (which was then located within the mesial temporal lobe). A biopsy performed on the left thalamic lesion in the first patient revealed a germinoma. The patient was treated with chemotherapy and died 2 years later. The second patient underwent a lumbar puncture, which demonstrated an elevated level of beta-human chorionic gonadotropin. Despite the lack of a mass on MR images in this child, the need for a tissue diagnosis prompted the authors to perform an anterior temporal lobectomy. The diagnosis of diffuse germinoma was confirmed, and the patient was treated with adjunctive chemotherapy. Although uncommon, germ cell tumors can present outside the midline and exhibit a multifocal growth pattern.


Subject(s)
Basal Ganglia/pathology , Brain Neoplasms/pathology , Germinoma/pathology , Biopsy , Brain Neoplasms/complications , Brain Neoplasms/diagnosis , Child , Diagnosis, Differential , Germinoma/complications , Germinoma/diagnosis , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male
7.
J Neurosurg ; 105(6): 908-11, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17405264

ABSTRACT

Ependymomas are glial tumors that occur most often in children. In adults, ependymomas most often appear in the spinal cord. The World Health Organization recognizes several rare ependymoma subtypes, including the giant cell ependymoma of the terminal filum. The authors describe an unusual case of a posterior fossa giant cell ependymoma in an 89-year-old man presenting with vertigo and disequilibrium. Only seven cases of this tumor have been reported in the literature to date. The authors discuss the clinical presentation, radiological findings, pathological considerations, and surgical intervention in this patient and review the relevant literature.


Subject(s)
Cerebellar Neoplasms/surgery , Cranial Fossa, Posterior/surgery , Ependymoma/surgery , Skull Base Neoplasms/surgery , Aged, 80 and over , Cerebellar Neoplasms/diagnosis , Cerebellar Neoplasms/pathology , Cerebellum/pathology , Cerebellum/surgery , Cranial Fossa, Posterior/pathology , Ependymoma/diagnosis , Ependymoma/pathology , Humans , Male , Neurologic Examination , Postoperative Complications/diagnosis , Postural Balance/physiology , Skull Base Neoplasms/diagnosis , Skull Base Neoplasms/pathology , Tomography, X-Ray Computed , Vertigo/etiology
8.
Cancer ; 103(12): 2598-605, 2005 Jun 15.
Article in English | MEDLINE | ID: mdl-15861411

ABSTRACT

BACKGROUND: Published research on the clinicopathologic features of extraventricular ependymal neoplasms of the cerebral hemispheres has been scant. METHODS: Thirty-two archival cases were studied to investigate the prognostic impact of clinicopathologic parameters including flow cytometry, the proliferation (Ki-67) labeling index, and p53 expression. RESULTS: Among these 32 cases were 2 subependymomas, 19 ependymomas, and 11 anaplastic ependymomas. No significant gender predilection was observed, and 45% of patients were in their second or third decade of life. The left cerebral hemisphere was 1.5 times more commonly involved. On available imaging studies, lesions were often cystic, with or without a mural nodule. Tumors expressed glial fibrillary acidic protein (87%), S-100 protein (77%), cytokeratin (43%), and epithelial membrane antigen (17%). Ki-67 proliferation index paralleled tumor grade. Immunoreactivity for p53 protein was observed in the 2 cases of subependymoma, in 10 of 11 anaplastic ependymomas, and in 6 of 17 ependymomas. Flow cytometry performed in 27 tumors revealed diploidy in 20 cases and aneuploidy in 4 cases (3 anaplastic and 1 classic ependymomas), with S-phase fraction ranging from 0.2-9.7. Eleven subjects were additionally treated with radiotherapy, and 3 with chemotherapy. Follow up was available in 25 (78%) patients. CONCLUSIONS: The results of the current study suggest that there is no significant relation between histopathology, Ki-67 proliferation index, p53 immunolabeling, tumor ploidy, and biologic behavior.


Subject(s)
Brain Neoplasms/pathology , Cerebral Ventricle Neoplasms/pathology , Ependymoma/pathology , Glioma, Subependymal/pathology , Supratentorial Neoplasms/pathology , Adolescent , Adult , Aged , Brain Neoplasms/metabolism , Brain Neoplasms/therapy , Cell Proliferation , Cerebral Ventricle Neoplasms/metabolism , Cerebral Ventricle Neoplasms/therapy , Child , Child, Preschool , Ependymoma/metabolism , Ependymoma/therapy , Female , Flow Cytometry , Glioma, Subependymal/metabolism , Glioma, Subependymal/therapy , Humans , Infant , Ki-67 Antigen/metabolism , Male , Middle Aged , Ploidies , Prognosis , S Phase , Supratentorial Neoplasms/metabolism , Supratentorial Neoplasms/therapy , Tumor Suppressor Protein p53
9.
Diagn Cytopathol ; 31(6): 420-2, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15540182

ABSTRACT

Erdheim-Chester disease (ECD) is an uncommon, systemic xanthogranulomatous disorder, with distinct clinicopathological features, that is rarely expected preoperatively. We describe a case that presented in the brain of a 26-yr-old male patient and clinically mimicked the appearance of a neoplasm. The final diagnosis was a surprise. In retrospect, the diagnosis was suggested by the intraoperative "squash" preparations, which demonstrated a mixed cellular proliferation of lymphohistiocytic elements and large, multinucleated cells with vesicular nuclei, prominent nucleoli, and abundant cytoplasm. To the best of our knowledge, this is the first report detailing the cytopathological features of ECD.


Subject(s)
Brain Diseases/pathology , Erdheim-Chester Disease/pathology , Adult , Brain Diseases/diagnostic imaging , Cytodiagnosis , Erdheim-Chester Disease/diagnostic imaging , Humans , Male , Radiography
10.
Mol Genet Metab ; 82(3): 192-207, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15234332

ABSTRACT

To better understand the pathogenesis of brain dysfunction in Gaucher disease (GD), we studied brain pathology in seven subjects with type 1 GD (four also exhibited parkinsonism and dementia), three with type 2 GD and four with type 3 GD. Unique pathologic patterns of disease involving the hippocampal CA2-4 regions and layer 4b of the calcarine cortex were identified. While these findings were common to all three GD phenotypes, the extent of the changes varied depending on the severity of disease. Cerebral cortical layers 3 and 5, hippocampal CA2-4, and layer 4b were involved in all GD patients. Neuronal loss predominated in both type 2 and type 3 patients with progressive myoclonic encephalopathy, whereas patients classified as type 1 GD had only astrogliosis. Adjacent regions and lamina, including hippocampal CA1 and calcarine lamina 4a and 4c were spared of pathology, highlighting the specificity of the vulnerability of selective neurons. Elevated glucocerebrosidase expression by immunohistochemistry was found in CA2-4. Hippocampal (45)Ca(2+) uptake autoradiography in rat brain was performed demonstrating that hippocampal CA2-4 neurons, rather than CA1 neurons, were calcium-induced calcium release sensitive (CICR-sensitive). These findings match recent biochemical studies linking elevated glucosylceramide levels to sensitization of CA2-4 RyaR receptors and 300% potentiation of neuronal CICR sensitivity. In two patients with type 1 GD and parkinsonism, numerous synuclein positive inclusions, similar to brainstem-type Lewy bodies found in Parkinson disease, were also found hippocampal CA2-4 neurons. These findings argue for a common cytotoxic mechanism linking aberrant glucocerebrosidase activity, neuronal cytotoxicity, and cytotoxic Lewy body formation in GD.


Subject(s)
Brain/pathology , Gaucher Disease/physiopathology , Neurons/pathology , Adolescent , Aged , Aged, 80 and over , Animals , Astrocytes/pathology , Autoradiography , Calcium Radioisotopes/metabolism , Child , Child, Preschool , Epilepsies, Myoclonic/complications , Female , Gaucher Disease/complications , Glucosylceramidase/metabolism , Humans , Immunohistochemistry , Infant , Male , Middle Aged , Nerve Tissue Proteins/metabolism , Rats , Synucleins
11.
Mod Pathol ; 17(6): 679-83, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15105808

ABSTRACT

The central nervous system atypical teratoid/rhabdoid tumor (ATRT) is a highly malignant tumor with a heterogeneous immunohistochemical profile and with some morphologic similarity to central nervous system primitive neuroectodermal tumors (PNET). Although several studies have investigated double immunolabeling in PNET, we are aware of no studies of double labeling of ATRT. A total of 10 ATRT from surgical and consultation materials at the Children's Hospital of Philadelphia were selected and stained for a variety of antigens using indirect immunofluorescence to detect single and double labeling. Most tumor cells showed only single labeling; rare cells showed double labeling as follows: 70% of tumors coexpressed (VIM) and glial fibrillary acidic protein (GFAP), 30% smooth muscle actin and GFAP, 20% epithelial membrane antigen (EMA) and VIM, 20% EMA/GFAP, and 20% EMA/SMA. These results are discussed in view of current debates over the histogenesis of CNS PNET and ATRT, and in reference to the classification of rhabdoid tumors as an entity or phenotype.


Subject(s)
Central Nervous System Neoplasms/metabolism , Immunohistochemistry/methods , Rhabdoid Tumor/metabolism , Teratoma/metabolism , Actins/analysis , Central Nervous System Neoplasms/pathology , Child , Child, Preschool , Female , Glial Fibrillary Acidic Protein/analysis , Humans , Infant , Male , Mucin-1/analysis , Muscle, Smooth/chemistry , Neurofilament Proteins/analysis , Rhabdoid Tumor/pathology , Teratoma/pathology , Vimentin/analysis
12.
Mod Pathol ; 16(3): 236-45, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12640104

ABSTRACT

"Primary" ear and temporal bone meningiomas are tumors that are frequently misdiagnosed and unrecognized, resulting in inappropriate clinical management. To date, a large clinicopathologic study of meningiomas in this anatomic site has not been reported. Thirty-six cases of ear and temporal bone meningiomas diagnosed between 1970 and 1996 were retrieved from our files. Histologic features were reviewed, immunohistochemical analysis was performed (n = 19), and patient follow-up was obtained (n = 35). The patients included 24 females and 12 males, aged 10-80 years (mean, 49.6 years), with female patients presenting at an older age (mean, 52.0 years) than male patients (mean, 44.8 years). Patients presented clinically with hearing changes (n = 20), otitis (n = 7), pain (n = 5), and/or dizziness/vertigo (n = 3). Symptoms were present for an average of 24.6 months. The tumors affected the middle ear (n = 25), external auditory canal (n = 4), or a combination of temporal bone and middle ear (n = 7). The tumors ranged in size from 0.5 to 4.5 cm in greatest dimension (mean, 1.2 cm). Radiographic studies demonstrated a central nervous system connection in 2 patients. Histologically, the tumors demonstrated features similar to those of intracranial meningiomas, including meningothelial (n = 33), psammomatous (n = 2), and atypical (n = 1). An associated cholesteatoma was identified in 9 cases. Immunohistochemical studies confirmed the diagnosis of meningioma with positive reactions for epithelial membrane antigen (79%) and vimentin (100%). The differential diagnosis includes paraganglioma, schwannoma, carcinoma, melanoma, and middle ear adenoma. Surgical excision was used in all patients. Ten patients developed a recurrence from 5 months to 2 years later. Five patients died with recurrent disease (mean, 3.5 years), and the remaining 30 patients were alive (n = 25, mean: 19.0 years) or had died (n = 5, mean: 9.5 years) of unrelated causes without evidence of disease. We conclude that extracranial ear and temporal bone meningiomas are rare tumors histologically similar to their intracranial counterparts. They behave as slow-growing neoplasms with a good overall prognosis (raw 5-y survival, 83%). Extent of surgical excision is probably the most important factor in determining outlook because recurrences develop in 28% of cases.


Subject(s)
Ear Neoplasms/pathology , Meningeal Neoplasms/pathology , Meningioma/pathology , Temporal Bone/pathology , Adenoma/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma/pathology , Child , Diagnosis, Differential , Ear Neoplasms/metabolism , Ear Neoplasms/mortality , Ear Neoplasms/physiopathology , Female , Follow-Up Studies , Humans , Immunohistochemistry , Male , Melanoma/pathology , Meningeal Neoplasms/metabolism , Meningeal Neoplasms/mortality , Meningeal Neoplasms/physiopathology , Meningioma/metabolism , Meningioma/mortality , Meningioma/physiopathology , Middle Aged , Neoplasm Recurrence, Local , Neurilemmoma/pathology , Paraganglioma/pathology , Prognosis , Temporal Bone/metabolism
13.
Mod Pathol ; 15(11): 1197-204, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12429799

ABSTRACT

Telepathology is the practice of digitizing histological or macroscopic images for transmission along telecommunication pathways for diagnosis, consultation, or continuing medical education. Previous studies have addressed static versus dynamic imaging in several specimen types with a wide variety of systems and communication pathways. The goal of this paper was to assess the validity of a Web-based telepathology system for frozen section consultation within the Army Medical Department. The system provides real-time, dynamic remote control of a robotic microscope over standard Internet connections. Oftentimes, a solo pathologist is called on to provide diagnostic services without the support of immediate second or expert consultation during an intraoperative consultation. The use of telepathology is attractive because it provides an opportunity for pathologists to obtain immediate consultation. For purposes of the study, 120 consecutive frozen section cases were diagnosed at a distance using the system. Intraobserver agreement between the telepathology diagnosis and glass slide diagnosis was observed. Diagnostic agreement was 100% for a wide variety of specimens. This study suggests that such a system will help support pathologists located at distant sites.


Subject(s)
Robotics/methods , Telepathology/methods , Cytodiagnosis/methods , Frozen Sections , Humans , Reproducibility of Results , Retrospective Studies , Telepathology/instrumentation
14.
Radiographics ; 22(6): 1473-505, 2002.
Article in English | MEDLINE | ID: mdl-12432118

ABSTRACT

Intraventricular neoplasms are readily seen on cross-sectional images, but the myriad possibilities may make a focused differential diagnosis elusive. Consideration of the tissue within and composing the ventricular lining and the clinical findings provide the means to limit the differential diagnosis when analyzing an intraventricular mass on an imaging study. Ependymomas are typically calcified, are more common in children, are more common in the fourth ventricle, and show intense enhancement on contrast-enhanced images. Subependymomas and central neurocytomas have an affinity for the anterior portion of the lateral ventricle, and both commonly demonstrate a heterogeneous cystic appearance on cross-sectional images. Subependymomas are more common in older adults, whereas central neurocytomas are more common before 40 years of age. Subependymal giant cell astrocytomas always lie near the foramen of Monro and are characterized by frequent calcification, intense enhancement on contrast-enhanced studies, and the presence of other stigmata seen in tuberous sclerosis. When a mass is centered on the choroid plexus, a highly vascular tumor-either choroid plexus papilloma, choroid plexus carcinoma, meningioma, or metastasis-should be suspected. The characteristic heavily lobulated appearance of a choroid plexus tumor favors this diagnosis over other possibilities, although it is not always possible to distinguish between the more common benign form, the choroid plexus papilloma, and the less common malignant counterpart, the choroid plexus carcinoma. By using clinical, demographic, and imaging findings, one can significantly limit the differential diagnosis for many of the most common intraventricular neoplasms.


Subject(s)
Cerebral Ventricle Neoplasms/diagnostic imaging , Cerebral Ventricle Neoplasms/pathology , Tomography, X-Ray Computed , Diagnosis, Differential , Humans , Neoplasm Metastasis
SELECTION OF CITATIONS
SEARCH DETAIL
...